Cullen B R
Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710.
Infect Agents Dis. 1994 Apr-Jun;3(2-3):68-76.
The quantity and quality of human immunodeficiency virus type 1 (HIV-1) gene expression is controlled in large part by the action of two small nuclear viral regulatory proteins termed Tat and Rev. Tat is unique among transcriptional trans-activators in that it acts via a structured RNA target sequence, termed TAR, to induce high levels of transcription from the HIV-1 long terminal repeat promoter element. The activity of the viral Rev protein is also unprecedented in that this protein functions to induce the nuclear export of a specific class of viral RNA species that are otherwise sequestered in the nucleus by the action of cellular factors. Like Tat, Rev also interacts with a highly specific cis-acting target sequence termed, in this case, the Rev Response Element. In this review, I provide an outline of our current understanding of the roles and mechanisms of action of these two novel RNA-sequence-dependent regulatory proteins.
1型人类免疫缺陷病毒(HIV-1)基因表达的数量和质量在很大程度上受两种称为Tat和Rev的小核病毒调节蛋白的作用控制。Tat在转录反式激活因子中是独特的,因为它通过一个称为TAR的结构化RNA靶序列起作用,以诱导HIV-1长末端重复启动子元件高水平转录。病毒Rev蛋白的活性也是前所未有的,因为这种蛋白的功能是诱导一类特定的病毒RNA物种的核输出,否则这些病毒RNA会因细胞因子的作用而被隔离在细胞核中。与Tat一样,Rev也与一个高度特异性的顺式作用靶序列相互作用,在这种情况下称为Rev反应元件。在这篇综述中,我概述了我们目前对这两种新型RNA序列依赖性调节蛋白的作用和作用机制的理解。